Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Could Eli Lilly Stock Help You Become a Millionaire?: https://g.foolcdn.com/editorial/images/765978/rich-couple-on-a-boat.jpg
Could Eli Lilly Stock Help You Become a Millionaire?

Eli Lilly (NYSE: LLY) has been on a tear this past year, rising up to become the most valuable healthcare stock in the world. It soared past UnitedHealth Group and other top healthcare companies in

Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript

Image source: The Motley Fool.

Dynavax Technologies (NASDAQ: DVAX)Q4 2023 Earnings CallFeb 22, 2024, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Where Will Medtronic Stock Be in 3 Years?: https://g.foolcdn.com/editorial/images/765981/medical-professional-smiling.jpg
Where Will Medtronic Stock Be in 3 Years?

Medtronic (NYSE: MDT) is a leading medical device company that aims to simplify patients' everyday lives. And with a broad presence that spans 150 countries, treating more than 70 health conditions

2 Monster Stocks to Buy Without Any Hesitation: https://g.foolcdn.com/editorial/images/765695/physician-giving-a-high-five-to-a-young-patient.jpg
2 Monster Stocks to Buy Without Any Hesitation

Investing in stocks is a great way for most people to grow their wealth over time. However, all stocks aren't created equal. Some are unlikely to deliver anything resembling solid returns over the

Better Bull Market Buy: Novavax vs. Pfizer: https://g.foolcdn.com/editorial/images/765997/gettyimages-1362265065.jpg
Better Bull Market Buy: Novavax vs. Pfizer

It's official: The S&P 500 is in a bull market after reaching a new all-time high last month. The index actually has been in this positive market phase ever since it started recovering from its bear

Better Bull Market Buy: Novavax vs. Pfizer: https://g.foolcdn.com/editorial/images/765997/gettyimages-1362265065.jpg
Better Bull Market Buy: Novavax vs. Pfizer

It's official: The S&P 500 is in a bull market after reaching a new all-time high last month. The index actually has been in this positive market phase ever since it started recovering from its bear

Is AbbVie Stock a Buy Now?: https://g.foolcdn.com/editorial/images/765217/drug-development-pharmaceutical-pharma-research-researchers-doctors.jpg
Is AbbVie Stock a Buy Now?

Pharmaceutical giant AbbVie (NYSE: ABBV) is getting used to life without Humira. Not literally, but the former global top-seller did lose patent exclusivity last year, and sales plummeted as cheaper

EQS-News: Gerresheimer decisively continues on profitable growth course in financial year 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
EQS-News: Gerresheimer decisively continues on profitable growth course in financial year 2023
EQS-News: Gerresheimer decisively continues on profitable growth course in financial year 2023
These 3 Dividend Stocks Yield More Than 5% but Their Payout Ratios Are Over 100%. Are Dividend Cuts Coming?: https://g.foolcdn.com/editorial/images/765794/people-looking-at-a-chart-on-a-laptop.jpg
These 3 Dividend Stocks Yield More Than 5% but Their Payout Ratios Are Over 100%. Are Dividend Cuts Coming?

High-yielding dividend stocks can make for attractive investments given the potential income they can generate for your portfolio. But there is often a trade-off when it comes to high payouts, as

These 3 Dividend Stocks Yield More Than 5% but Their Payout Ratios Are Over 100%. Are Dividend Cuts Coming?: https://g.foolcdn.com/editorial/images/765794/people-looking-at-a-chart-on-a-laptop.jpg
These 3 Dividend Stocks Yield More Than 5% but Their Payout Ratios Are Over 100%. Are Dividend Cuts Coming?

High-yielding dividend stocks can make for attractive investments given the potential income they can generate for your portfolio. But there is often a trade-off when it comes to high payouts, as

2 No-Brainer Biotech Stocks to Buy Right Now: https://g.foolcdn.com/editorial/images/765481/doctor-and-patient-talking.jpg
2 No-Brainer Biotech Stocks to Buy Right Now

Those looking to invest in stocks can sometimes seem spoiled for choices. There are all kinds of businesses in the equity markets that seem intriguing. However, upon closer inspection, many of these

2 No-Brainer Biotech Stocks to Buy Right Now: https://g.foolcdn.com/editorial/images/765481/doctor-and-patient-talking.jpg
2 No-Brainer Biotech Stocks to Buy Right Now

Those looking to invest in stocks can sometimes seem spoiled for choices. There are all kinds of businesses in the equity markets that seem intriguing. However, upon closer inspection, many of these

2 No-Brainer Biotech Stocks to Buy Right Now: https://g.foolcdn.com/editorial/images/765481/doctor-and-patient-talking.jpg
2 No-Brainer Biotech Stocks to Buy Right Now

Those looking to invest in stocks can sometimes seem spoiled for choices. There are all kinds of businesses in the equity markets that seem intriguing. However, upon closer inspection, many of these

Is Medtronic Stock a Buy Now?: https://g.foolcdn.com/editorial/images/765216/medical-professionals-consulting.jpg
Is Medtronic Stock a Buy Now?

Every long-term investor should have at least some healthcare stocks in their portfolio. People will always need care, and the industry constantly looks for new and better ways to provide it

QuidelOrtho Announces Changes in Executive Leadership: https://mms.businesswire.com/media/20240221157769/en/2040201/5/1x1-robert-bujarski_1-1.jpg
QuidelOrtho Announces Changes in Executive Leadership


The Board of Directors (the “Board”) of QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”) has made significant decisions aimed to enhance operational efficiency, drive revenue

Why Medtronic Stock Jumped Today: https://g.foolcdn.com/editorial/images/766103/doctors-reviewing-information-on-tablet-computer.jpg
Why Medtronic Stock Jumped Today

Shares of Medtronic (NYSE: MDT) climbed as much as 3.3% early Tuesday, and then settled to close up around 1.7%, after the medical-device company announced strong fiscal third-quarter results and

Axsome Therapeutics (AXSM) Q4 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Axsome Therapeutics (AXSM) Q4 2023 Earnings Call Transcript

Image source: The Motley Fool.

Axsome Therapeutics (NASDAQ: AXSM)Q4 2023 Earnings CallFeb 20, 2024, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com

Henry Ford Health and Acadia Healthcare Appoint Emily Sexton as CEO of New Henry Ford Behavioral Health Hospital: https://mms.businesswire.com/media/20240220715559/en/2039326/5/ACHCSexton_Emily_21_Headshot.jpg
Henry Ford Health and Acadia Healthcare Appoint Emily Sexton as CEO of New Henry Ford Behavioral Health Hospital


Henry Ford Health, one of the nation’s premier academic and integrated health systems, and Acadia Healthcare, the nation’s largest stand-alone behavioral healthcare company, today announced the

Medtronic (MDT) Q3 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Medtronic (MDT) Q3 2024 Earnings Call Transcript

Image source: The Motley Fool.

Medtronic (NYSE: MDT)Q3 2024 Earnings CallFeb 20, 2024, 8:00 a.m. ET

Ryan Weispfenning

Continue reading

Source Fool.com

CenterWell Pharmacy furthers digital strategy with launch of new mobile app: https://mms.businesswire.com/media/20240220421468/en/2038601/5/Fill_new_bottom_sheet.jpg
CenterWell Pharmacy furthers digital strategy with launch of new mobile app


CenterWell Pharmacy® has introduced a new mobile app that lets customers manage their prescriptions anytime and anywhere, requesting refills, shopping for over-the-counter products, tracking orders

Vertex Pharmaceuticals Is About to Extend Its Leadership in This Billion-Dollar Market: https://g.foolcdn.com/editorial/images/765901/gettyimages-968838136.jpg
Vertex Pharmaceuticals Is About to Extend Its Leadership in This Billion-Dollar Market

Vertex Pharmaceuticals (NASDAQ: VRTX) has wowed investors in recent times as it's expanded beyond its specialty area of cystic fibrosis (CF) treatment. The company launched Casgevy, a one-time

Vertex Pharmaceuticals Is About to Extend Its Leadership in This Billion-Dollar Market: https://g.foolcdn.com/editorial/images/765901/gettyimages-968838136.jpg
Vertex Pharmaceuticals Is About to Extend Its Leadership in This Billion-Dollar Market

Vertex Pharmaceuticals (NASDAQ: VRTX) has wowed investors in recent times as it's expanded beyond its specialty area of cystic fibrosis (CF) treatment. The company launched Casgevy, a one-time

Vertex Pharmaceuticals Is About to Extend Its Leadership in This Billion-Dollar Market: https://g.foolcdn.com/editorial/images/765901/gettyimages-968838136.jpg
Vertex Pharmaceuticals Is About to Extend Its Leadership in This Billion-Dollar Market

Vertex Pharmaceuticals (NASDAQ: VRTX) has wowed investors in recent times as it's expanded beyond its specialty area of cystic fibrosis (CF) treatment. The company launched Casgevy, a one-time

Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought: https://g.foolcdn.com/editorial/images/765827/gettyimages-1197547531.jpg
Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought

Cathie Wood's success is based on two main things: finding innovators and betting on them for the long term. The founder and chief executive officer of Ark Invest goes for innovators in all areas

EQS-Adhoc: Bayer Aktiengesellschaft: Bayer plans to amend its dividend policy to reduce debt: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24691/Logo_der_Bayer_AG.svg.png
EQS-Adhoc: Bayer Aktiengesellschaft: Bayer plans to amend its dividend policy to reduce debt
EQS-Adhoc: Bayer Aktiengesellschaft: Bayer plans to amend its dividend policy to reduce debt